Humana (NYSE:HUM) Hits New 1-Year High – Here’s What Happened

Humana Inc. (NYSE:HUM) shares hit a new 52-week high on Wednesday . The stock traded as high as $380.86 and last traded at $369.78, with a volume of 1697078 shares. The stock had previously closed at $380.26.

Wall Street Analyst Weigh In

A number of analysts recently commented on HUM shares. Needham & Company LLC initiated coverage on shares of Humana in a report on Wednesday, May 20th. They set a “buy” rating on the stock. Weiss Ratings upgraded shares of Humana from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, June 12th. Barclays boosted their price target on Humana from $180.00 to $344.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 26th. Zacks Research upgraded Humana from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 13th. Finally, Evercore raised their price objective on Humana from $250.00 to $370.00 in a research note on Thursday, June 11th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, sixteen have assigned a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $291.35.

Humana Price Performance

The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market capitalization of $43.32 billion, a PE ratio of 38.59, a P/E/G ratio of 2.06 and a beta of 0.76. The company’s fifty day simple moving average is $282.64 and its two-hundred day simple moving average is $240.76.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The company’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts predict that Humana Inc. will post 9.04 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. Humana’s dividend payout ratio is presently 37.86%.

Hedge Funds Weigh In On Humana

Hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in shares of Humana by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,261,860 shares of the insurance provider’s stock valued at $3,652,890,000 after acquiring an additional 106,030 shares during the last quarter. Capital International Investors raised its stake in Humana by 113.9% in the 4th quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares during the last quarter. Pzena Investment Management LLC raised its stake in Humana by 34.3% in the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock valued at $948,614,000 after purchasing an additional 1,398,774 shares during the last quarter. State Street Corp lifted its holdings in Humana by 1.8% in the 4th quarter. State Street Corp now owns 5,462,549 shares of the insurance provider’s stock valued at $1,403,877,000 after purchasing an additional 97,211 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Humana by 28.9% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,496,775 shares of the insurance provider’s stock valued at $1,151,759,000 after purchasing an additional 1,008,514 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.